Q4 FY2026 · ended Jun 30, 2026 · Revenue $19.42M, +11.6% YoY · Filed Aug 25, 2026
Electromed, Inc. (ELMD) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q4 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $19.4 million and net income of $3.4 million. Free cash flow was $2.8 million. As of Jun 30, 2026 it held $20.4 million in cash and investments and $133,000 in total debt.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- ELMD (NYSE)
- Fiscal year ends
- June 30
- Incorporated in
- MN
- Headquarters
- New Prague, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1488917
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q4 FY2026 Jun 30, 2026 |
Q3 FY2026 Mar 31, 2026 |
Q2 FY2026 Dec 31, 2025 |
Q1 FY2026 Sep 30, 2025 |
Q4 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $19.4M | $18.6M | $18.9M | $16.9M | $17.4M |
| Operating income | $3.8M | $3.8M | $3.6M | $2.7M | $3.0M |
| Net income | $3.4M | $3.0M | $2.8M | $2.1M | $2.2M |
| Diluted EPS | $0.39 | $0.35 | $0.32 | $0.25 | $0.25 |
| Operating cash flow | $3.0M | $3.5M | $3.0M | $169,000 | $3.9M |
| Free cash flow | $2.8M | $3.3M | $2.4M | -$83,000 | $3.7M |
| Total assets | $66.3M | $59.5M | $54.9M | $53.6M | $53.8M |
| Total liabilities | $12.3M | $10.3M | $9.5M | $8.9M | $10.6M |
| Stockholders' equity | $54.0M | $49.2M | $45.4M | $44.7M | $43.2M |
| Cash and investments | $20.4M | $17.0M | $13.8M | $14.1M | $15.3M |
| Total debt | $133,000 | — | — | — | $198,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Sep 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 25, 2026 | Aug 25, 2026 |
| 10-K | Annual report | Aug 25, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | Feb 10, 2026 | Dec 31, 2025 |
All 578 Electromed, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.